PERCF (Percheron Therapeutics) Beginning Cash Position: $6.76 Mil (As of Dec. 2025)


What is Percheron Therapeutics Beginning Cash Position?

Percheron Therapeutics PERCF -0.18% Beginning Cash Position is $6.76 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Percheron Therapeutics's Beginning Cash Position for the quarter that ended in Dec. 2025 was $6.76 Mil.

Percheron Therapeutics's quarterly Beginning Cash Position increased from Dec. 2024 ($7.52 Mil) to Jun. 2025 ($11.32 Mil) but then declined from Jun. 2025 ($11.32 Mil) to Dec. 2025 ($6.76 Mil).

Percheron Therapeutics's annual Beginning Cash Position declined from Jun. 2023 ($12.91 Mil) to Jun. 2024 ($7.28 Mil) but then increased from Jun. 2024 ($7.28 Mil) to Jun. 2025 ($7.73 Mil).

Percheron Therapeutics Beginning Cash Position Related Terms

Percheron Therapeutics Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Percheron Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Percheron Therapeutics Beginning Cash Position Chart

Percheron Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.10 4.23 12.91 7.28 7.73

Percheron Therapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.34 11.42 7.52 11.32 6.76

Percheron Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $6.76 Mil mean?
Percheron Therapeutics (PERCF) has a Beginning Cash Position of $6.76 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Percheron Therapeutics and its competitors.
Is Percheron Therapeutics' Beginning Cash Position too high?
Percheron Therapeutics' current Beginning Cash Position is $6.76 Mil.
How does Percheron Therapeutics' Beginning Cash Position compare to ZTS and UTHR?
Percheron Therapeutics' Beginning Cash Position of $6.76 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Percheron Therapeutics and its competitors. Percheron Therapeutics's current Beginning Cash Position is $6.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Percheron Therapeutics stock overvalued right now?
Percheron Therapeutics (PERCF) has a current Beginning Cash Position of $6.76 Mil. The current Beginning Cash Position is $6.76 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Percheron Therapeutics (PERCF), the current Beginning Cash Position is $6.76 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Percheron Therapeutics Business Description

Other Exchanges AWY0:GermanyPER:Australia
Address 35 Collins Street, Level 30, Collins Place, Melbourne, VIC, AUS, 3000
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.